Financial Performance - Net Revenue for Q2 2025 reached $3,148 million, a 29.1% increase from $2,438 million in Q2 2024[3] - Gross Profit for Q2 2025 was $375 million, up 20.1% compared to $312 million in Q2 2024[3] - Adjusted EBITDA for Q2 2025 was $143 million, reflecting a 28.8% increase from $111 million in Q2 2024[3] - Net Income from Continuing Operations for Q2 2025 was $8.5 million, unchanged from Q2 2024[3] - Total revenues for Q2 2025 reached $3,147.7 million, a 29% increase from $2,438.3 million in Q2 2024[29] - Net income attributable to BrightSpring Health Services, Inc. for Q2 2025 was $28.2 million, up from $19.9 million in Q2 2024, representing a 42% increase[29] - Operating income for the six months ended June 30, 2025, was $99.3 million, significantly higher than $23.3 million for the same period in 2024[29] - Net income for the three months ended June 30, 2025, was $27,542,000, compared to $19,441,000 for the same period in 2024, representing an increase of 41.5%[31] - Adjusted EBITDA for the six months ended June 30, 2025, was $273,579,000, up from $212,852,000 in 2024, reflecting a growth of 28.6%[33] Revenue Guidance - Full Year 2025 Revenue guidance increased to between $12,200 million and $12,600 million, representing growth of 21.1% to 25.1%[5] - Adjusted EBITDA guidance for 2025 is now projected to be between $590 million and $605 million, indicating growth of 28.2% to 31.5%[9] - Pharmacy Segment Revenue for 2025 is expected to be between $10,750 million and $11,100 million, reflecting growth of 22.8% to 26.8%[9] - Provider Segment Revenue for 2025 is projected to be between $1,450 million and $1,500 million, showing growth of 10.0% to 13.8%[9] Assets and Liabilities - Total current assets increased to $2,648.0 million as of June 30, 2025, compared to $1,893.1 million at December 31, 2024, marking a 40% growth[27] - Total liabilities decreased to $4,198.2 million as of June 30, 2025, down from $4,274.6 million at December 31, 2024, indicating a reduction of approximately 2%[27] - Total shareholders' equity rose to $1,742.9 million as of June 30, 2025, compared to $1,647.9 million at December 31, 2024, an increase of 6%[27] Cash Flow and Expenses - Cash and cash equivalents rose to $70.1 million as of June 30, 2025, compared to $61.0 million at December 31, 2024, an increase of 18%[27] - The company reported a net cash provided by operating activities of $150,674,000 for the six months ended June 30, 2025, compared to a net cash used of $(94,084,000) in 2024[31] - The net cash used in investing activities was $(47,434,000) for the six months ended June 30, 2025, compared to $(88,630,000) in 2024[31] - The company incurred $19,828,000 in acquisition, integration, and transaction-related costs for the three months ended June 30, 2025, compared to $5,021,000 in 2024[33] Shareholder Metrics - The company reported a basic income per share of $0.14 for Q2 2025, compared to $0.10 for Q2 2024, reflecting a 40% increase[29] - Diluted EPS for the three months ended June 30, 2025, was $0.04, consistent with the same period in 2024, while Adjusted EPS increased to $0.22 from $0.06[34] Business Operations - The company continues to focus on delivering high-quality care and operational excellence across prioritized markets and services[2] - The planned divestiture of the Community Living business to Sevita is expected to occur in Q4 2025[5] - The company’s goodwill increased slightly to $2,370.1 million as of June 30, 2025, from $2,363.9 million at December 31, 2024[27] - Total adjustments to reconcile net income to Adjusted EBITDA amounted to $91,612,000 for the six months ended June 30, 2025, compared to $123,324,000 in 2024[33] - The company had long-term debt repayments of $23,720,000 for the six months ended June 30, 2025, compared to $3,370,970,000 in 2024[31] - The company reported a provision for credit losses of $32,557,000 for the three months ended June 30, 2025, compared to $6,496,000 in 2024[31]
Brightspring Health Services, Inc.(BTSGU) - 2025 Q2 - Quarterly Results